Catalyst Pharmaceutical Partners, Inc.
Catalyst Pharmaceutical Partners, Inc. (CPRX) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 596 transactions totaling $89.1M, demonstrating a bearish sentiment with -$74.8M in net insider flow. The most recent transaction on Dec 29, 2025 involved a transaction of 6,786 shares valued at $0.
CPRX Insider Activity Summary
Who Is Buying CPRX Stock?
No significant insider buying has been recorded for CPRX in the recent period.
Who Is Selling CPRX Stock?
No significant insider selling has been recorded for CPRX in the recent period.
Is Catalyst Pharmaceutical Partners, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CPRX is bearish with an Insider Alignment Score of 8/100 and a net flow of -$74.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CPRX Frequently Asked Questions
Understanding CPRX Insider Activity
Insider trading at Catalyst Pharmaceutical Partners, Inc. (CPRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading CPRX stock, having executed 596 transactions in the past 90 days. The most active insider is Patrick J. Mcenany (Executive), who has made 109 transactions totaling $34.4M.
Related Tools
Track Catalyst Pharmaceutical Partners, Inc. Insider Activity
Get notified when executives and directors at CPRX file new Form 4 transactions